ID   PTGES_HUMAN             Reviewed;         152 AA.
AC   O14684; O14900; Q5SZC0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=Prostaglandin E synthase;
DE            EC=5.3.99.3;
DE   AltName: Full=Microsomal glutathione S-transferase 1-like 1;
DE            Short=MGST1-L1;
DE   AltName: Full=Microsomal prostaglandin E synthase 1;
DE            Short=MPGES-1;
DE   AltName: Full=p53-induced gene 12 protein;
GN   Name=PTGES; Synonyms=MGST1L1, MPGES1, PGES, PIG12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION BY TP53.
RC   TISSUE=Colon cancer;
RX   PubMed=9305847; DOI=10.1038/38525;
RA   Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B.;
RT   "A model for p53-induced apoptosis.";
RL   Nature 389:300-306(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10377395; DOI=10.1073/pnas.96.13.7220;
RA   Jakobsson P.-J., Thoren S., Morgenstern R., Samuelsson B.;
RT   "Identification of human prostaglandin E synthase: a microsomal,
RT   glutathione-dependent, inducible enzyme, constituting a potential
RT   novel drug target.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:7220-7225(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10760517; DOI=10.1016/S0014-5793(00)01367-3;
RA   Forsberg L., Leeb L., Thoren S., Morgenstern R., Jakobsson P.J.;
RT   "Human glutathione dependent prostaglandin E synthase: gene structure
RT   and regulation.";
RL   FEBS Lett. 471:78-82(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   ENZYME KINETICS.
RX   PubMed=12460774; DOI=10.1016/S1046-5928(02)00566-1;
RA   Ouellet M., Falgueyret J.-P., Ear P.H., Pen A., Mancini J.A.,
RA   Riendeau D., Percival M.D.;
RT   "Purification and characterization of recombinant microsomal
RT   prostaglandin E synthase-1.";
RL   Protein Expr. Purif. 26:489-495(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   STRUCTURE BY ELECTRON CRYOMICROSCOPY.
RX   PubMed=12672824; DOI=10.1074/jbc.M303227200;
RA   Thoren S., Weinander R., Saha S., Jegerschold C., Pettersson P.L.,
RA   Samuelsson B., Hebert H., Hamberg M., Morgenstern R., Jakobsson P.-J.;
RT   "Human microsomal prostaglandin E synthase-1: purification, functional
RT   characterization, and projection structure determination.";
RL   J. Biol. Chem. 278:22199-22209(2003).
RN   [11]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.5 ANGSTROMS) IN COMPLEX WITH
RP   GLUTATHIONE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBCELLULAR
RP   LOCATION, TRANSMEMBRANE TOPOLOGY, AND MUTAGENESIS OF GLU-66; ARG-67;
RP   ARG-70; HIS-72; ARG-110 AND TYR-117.
RX   PubMed=18682561; DOI=10.1073/pnas.0802894105;
RA   Jegerschold C., Pawelzik S.C., Purhonen P., Bhakat P., Gheorghe K.R.,
RA   Gyobu N., Mitsuoka K., Morgenstern R., Jakobsson P.J., Hebert H.;
RT   "Structural basis for induced formation of the inflammatory mediator
RT   prostaglandin E2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:11110-11115(2008).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.16 ANGSTROMS) IN COMPLEXES WITH GLUTATIONE,
RP   SUBUNIT, AND PROBABLE TOPOLOGY.
RX   PubMed=23431194; DOI=10.1073/pnas.1218504110;
RA   Sjogren T., Nord J., Ek M., Johansson P., Liu G., Geschwindner S.;
RT   "Crystal structure of microsomal prostaglandin E2 synthase provides
RT   insight into diversity in the MAPEG superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:3806-3811(2013).
CC   -!- FUNCTION: Catalyzes the oxidoreduction of prostaglandin
CC       endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2).
CC       {ECO:0000269|PubMed:18682561}.
CC   -!- CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-
CC       hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-11-alpha,15-
CC       dihydroxy-9-oxoprosta-5,13-dienoate.
CC       {ECO:0000269|PubMed:18682561}.
CC   -!- COFACTOR:
CC       Name=glutathione; Xref=ChEBI:CHEBI:57925;
CC         Evidence={ECO:0000269|PubMed:18682561};
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:23431194}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18682561};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:18682561}.
CC   -!- INDUCTION: By p53/TP53. {ECO:0000269|PubMed:9305847}.
CC   -!- SIMILARITY: Belongs to the MAPEG family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF010316; AAC39534.1; -; mRNA.
DR   EMBL; AF027740; AAB82299.1; -; mRNA.
DR   EMBL; AJ271802; CAB72099.1; -; Genomic_DNA.
DR   EMBL; AJ271803; CAB72099.1; JOINED; Genomic_DNA.
DR   EMBL; AJ271804; CAB72099.1; JOINED; Genomic_DNA.
DR   EMBL; AK311947; BAG34888.1; -; mRNA.
DR   EMBL; EF543149; ABQ01233.1; -; Genomic_DNA.
DR   EMBL; AL590369; CAI14506.1; -; Genomic_DNA.
DR   EMBL; AL592219; CAI14506.1; JOINED; Genomic_DNA.
DR   EMBL; AL592219; CAI16116.1; -; Genomic_DNA.
DR   EMBL; AL590369; CAI16116.1; JOINED; Genomic_DNA.
DR   EMBL; BC008280; AAH08280.1; -; mRNA.
DR   CCDS; CCDS6927.1; -.
DR   RefSeq; NP_004869.1; NM_004878.4.
DR   UniGene; Hs.146688; -.
DR   PDB; 3DWW; EM; 3.50 A; A/B/C=1-152.
DR   PDB; 4AL0; X-ray; 1.16 A; A=1-152.
DR   PDB; 4AL1; X-ray; 1.95 A; A=1-152.
DR   PDB; 4BPM; X-ray; 2.08 A; A=10-152.
DR   PDB; 4WAB; X-ray; 2.70 A; A=10-151.
DR   PDB; 4YK5; X-ray; 1.42 A; A=2-152.
DR   PDB; 4YL0; X-ray; 1.52 A; A=5-152.
DR   PDB; 4YL1; X-ray; 1.41 A; A=5-152.
DR   PDB; 4YL3; X-ray; 1.41 A; A=5-152.
DR   PDB; 5BQG; X-ray; 1.44 A; A=2-152.
DR   PDB; 5BQH; X-ray; 1.60 A; A=2-152.
DR   PDB; 5BQI; X-ray; 1.88 A; A=2-152.
DR   PDB; 5K0I; X-ray; 1.30 A; A=2-152.
DR   PDB; 5T36; X-ray; 1.40 A; A=2-152.
DR   PDB; 5T37; X-ray; 1.76 A; A=2-152.
DR   PDB; 5TL9; X-ray; 1.20 A; A=2-152.
DR   PDBsum; 3DWW; -.
DR   PDBsum; 4AL0; -.
DR   PDBsum; 4AL1; -.
DR   PDBsum; 4BPM; -.
DR   PDBsum; 4WAB; -.
DR   PDBsum; 4YK5; -.
DR   PDBsum; 4YL0; -.
DR   PDBsum; 4YL1; -.
DR   PDBsum; 4YL3; -.
DR   PDBsum; 5BQG; -.
DR   PDBsum; 5BQH; -.
DR   PDBsum; 5BQI; -.
DR   PDBsum; 5K0I; -.
DR   PDBsum; 5T36; -.
DR   PDBsum; 5T37; -.
DR   PDBsum; 5TL9; -.
DR   ProteinModelPortal; O14684; -.
DR   SMR; O14684; -.
DR   BioGrid; 114912; 2.
DR   IntAct; O14684; 1.
DR   STRING; 9606.ENSP00000342385; -.
DR   BindingDB; O14684; -.
DR   ChEMBL; CHEMBL5658; -.
DR   GuidetoPHARMACOLOGY; 1377; -.
DR   SwissLipids; SLP:000001631; -.
DR   PhosphoSitePlus; O14684; -.
DR   SwissPalm; O14684; -.
DR   BioMuta; PTGES; -.
DR   EPD; O14684; -.
DR   MaxQB; O14684; -.
DR   PaxDb; O14684; -.
DR   PeptideAtlas; O14684; -.
DR   PRIDE; O14684; -.
DR   TopDownProteomics; O14684; -.
DR   Ensembl; ENST00000340607; ENSP00000342385; ENSG00000148344.
DR   GeneID; 9536; -.
DR   KEGG; hsa:9536; -.
DR   UCSC; uc004byi.4; human.
DR   CTD; 9536; -.
DR   DisGeNET; 9536; -.
DR   GeneCards; PTGES; -.
DR   HGNC; HGNC:9599; PTGES.
DR   HPA; HPA045064; -.
DR   MIM; 605172; gene.
DR   neXtProt; NX_O14684; -.
DR   OpenTargets; ENSG00000148344; -.
DR   PharmGKB; PA33948; -.
DR   eggNOG; ENOG410IY81; Eukaryota.
DR   eggNOG; ENOG4111VJG; LUCA.
DR   GeneTree; ENSGT00390000011980; -.
DR   HOGENOM; HOG000231759; -.
DR   HOVERGEN; HBG052470; -.
DR   InParanoid; O14684; -.
DR   KO; K15729; -.
DR   OMA; CFSMALQ; -.
DR   OrthoDB; EOG091G14I4; -.
DR   PhylomeDB; O14684; -.
DR   TreeFam; TF105327; -.
DR   BioCyc; MetaCyc:HS07518-MONOMER; -.
DR   BRENDA; 5.3.99.3; 2681.
DR   Reactome; R-HSA-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   SABIO-RK; O14684; -.
DR   ChiTaRS; PTGES; human.
DR   EvolutionaryTrace; O14684; -.
DR   GeneWiki; PTGES; -.
DR   GenomeRNAi; 9536; -.
DR   PRO; PR:O14684; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000148344; -.
DR   CleanEx; HS_PTGES; -.
DR   Genevisible; O14684; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005641; C:nuclear envelope lumen; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0043295; F:glutathione binding; IDA:UniProtKB.
DR   GO; GO:0050220; F:prostaglandin-E synthase activity; IDA:UniProtKB.
DR   GO; GO:0002526; P:acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0002544; P:chronic inflammatory response; IEA:Ensembl.
DR   GO; GO:0019371; P:cyclooxygenase pathway; TAS:Reactome.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   Gene3D; 1.20.120.550; -; 1.
DR   InterPro; IPR023352; MAPEG-like_dom.
DR   InterPro; IPR001129; Membr-assoc_MAPEG.
DR   Pfam; PF01124; MAPEG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Isomerase; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Prostaglandin biosynthesis;
KW   Prostaglandin metabolism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    152       Prostaglandin E synthase.
FT                                /FTId=PRO_0000217745.
FT   TOPO_DOM      1     12       Lumenal.
FT   TRANSMEM     13     41       Helical.
FT   TOPO_DOM     42     60       Cytoplasmic.
FT   TRANSMEM     61     90       Helical.
FT   TOPO_DOM     91     95       Lumenal.
FT   TRANSMEM     96    119       Helical.
FT   TOPO_DOM    120    123       Cytoplasmic.
FT   TRANSMEM    124    152       Helical.
FT   REGION       28     38       Glutathione binding.
FT   REGION       70     77       Glutathione binding.
FT   REGION      110    113       Glutathione binding.
FT   BINDING     117    117       Glutathione.
FT   BINDING     126    126       Glutathione.
FT   BINDING     130    130       Glutathione.
FT   BINDING     134    134       Glutathione.
FT   MUTAGEN      66     66       E->A: Reduces enzyme activity by 50%.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN      67     67       R->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN      70     70       R->A: Slightly reduced enzyme activity.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN      72     72       H->A: Reduces enzyme activity by 70%.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN     110    110       R->A,S: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN     117    117       Y->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:18682561}.
FT   MUTAGEN     117    117       Y->F: No effect on enzyme activity.
FT                                {ECO:0000269|PubMed:18682561}.
FT   CONFLICT     55     55       G -> GG (in Ref. 1; AAC39534).
FT                                {ECO:0000305}.
FT   HELIX         6      9       {ECO:0000244|PDB:5TL9}.
FT   HELIX        13     41       {ECO:0000244|PDB:4AL0}.
FT   STRAND       44     46       {ECO:0000244|PDB:4AL0}.
FT   HELIX        47     52       {ECO:0000244|PDB:4AL0}.
FT   HELIX        56     58       {ECO:0000244|PDB:4AL0}.
FT   HELIX        63     90       {ECO:0000244|PDB:4AL0}.
FT   HELIX        96    118       {ECO:0000244|PDB:4AL0}.
FT   HELIX       125    150       {ECO:0000244|PDB:4AL0}.
SQ   SEQUENCE   152 AA;  17102 MW;  BF9B9ED81CA67A3D CRC64;
     MPAHSLVMSS PALPAFLLCS TLLVIKMYVV AIITGQVRLR KKAFANPEDA LRHGGPQYCR
     SDPDVERCLR AHRNDMETIY PFLFLGFVYS FLGPNPFVAW MHFLVFLVGR VAHTVAYLGK
     LRAPIRSVTY TLAQLPCASM ALQILWEAAR HL
//
